Safety evaluation of selective RET inhibitors in patients with lung cancer: a real-world pharmacovigilance study [0.03%]
选择性RET抑制剂在肺癌患者中安全性的评价:一项基于真实世界药物警戒的研究
Yaokai Wang,Wenmei Jiang,Yun Cheng et al.
Yaokai Wang et al.
Objectives: Selpercatinib and pralsetinib are targeted therapies for non-small cell lung cancer. However, their adverse reaction profiles remain incompletely understood. This study aims to evaluate the post-marketing adve...
Digital workload in oncology trials: A comparative analysis of e-portal usage and operational insights from a single-center experience [0.03%]
肿瘤试验的数字工作量:单一中心电子平台使用情况及运营见解的比较分析
Stefano Stabile,Sara Mariano,Anna Bombelli et al.
Stefano Stabile et al.
Background: The digitalization of clinical research has increased reliance on electronic portals (e-portals), with significant implications for trial site operations. Our aim is to map the types and number of e-portals re...
Medical decision analysis for personalized oncology at the patient bedside [0.03%]
用于床旁肿瘤个性化治疗的医学决策分析
P G Casali,L Licitra,S Provenzano et al.
P G Casali et al.
Medical decision analysis is a method to make rational clinical decisions under uncertainty, enabling a mathematical combination of probabilities and utilities (i.e. values assigned to outcomes under risk). Decision analysis is commonly use...
Incidence, mortality and risk factors of hematologic malignancies in China from 1990 to 2021: A systematic analysis for the GBD 2021 [0.03%]
中国1990至2021年血液系统恶性肿瘤的发病、死亡及危险因素变化:全球疾病负担研究(GBD)2021系统分析结果
DongHui Gan,Jun Lin,JinFang Zeng et al.
DongHui Gan et al.
Objective: This study aimed to systematically analyze the incidence, mortality, and risk factors of hematologic malignancies and their subtypes in China from 1990-2021. ...
Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma [0.03%]
胰腺导管腺癌中胚系突变的流行病学和影响
Emir Gokhan Kahraman,Halil Taskaynatan,Taha Reşid Özdemir et al.
Emir Gokhan Kahraman et al.
Background: Germline pathogenic variants are increasingly recognized as critical determinants of pancreatic ductal adenocarcinoma (PDAC) susceptibility, prognosis, and response to targeted therapies such as PARP inhibitor...
Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes [0.03%]
持续性低级别宫颈上皮内瘤变期待观察治疗与锥切治疗的五年预后分析
Giorgio Bogani,Francesco Sopracordevole,Giovanni Corso et al.
Giorgio Bogani et al.
Objective: To investigate to describe outcomes of conization or expectant management for women with persistent (>24 months) low-grade cervical intra-epithelial neoplasia. ...
Maura Massimino,Paolo Grampa,Luca Pellizzer et al.
Maura Massimino et al.
Background: Volunteers play an essential role in pediatric oncology. While they are driven by personal motivations, they usually receive specific training that may support or reshape their goals. ...
Trends in histological subtypes of cutaneous melanoma in the Netherlands from 1989 to 2023 - Influence of sunlight exposure and overdiagnosis [0.03%]
1989年至2023年荷兰黑色素瘤组织亚型趋势-阳光暴露和过度诊断的影响
Catharina C van Niekerk,André L M Verbeek,Erik Brummelkamp et al.
Catharina C van Niekerk et al.
Introduction: Melanoma incidence has continued to increase over the past decades with unchanged mortality. Different sunshine exposures across the generations complicate the interpretation of the trends. It is further sug...
Nutritional status as a risk factor for adverse events associated with L-Asparaginase in children with acute lymphoblastic leukemia [0.03%]
营养状况作为儿童急性淋巴细胞白血病阿糖胞苷不良反应的风险因素
Jesús Alonso Gándara-Mireles,Verónica Loera Castañeda,Ismael Lares-Assef et al.
Jesús Alonso Gándara-Mireles et al.
Background: Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, and asparaginase (ASNase) is a key component of its treatment. However, ASNase is frequently associated with adverse events (AEs), such a...
Central nervous system effectiveness of selpercatinib retreatment in heavily pretreated NSCLC patient with RET rearrangement: A case report [0.03%]
塞利帕利替尼对接受过多次治疗的RET融合阳性晚期非小细胞肺癌患者的中枢神经系统疗效:一例报告
Margherita Agostini,Samuele Compagno,Francesca Sperandi et al.
Margherita Agostini et al.
Introduction: RET-rearranged non-small cell lung cancer (NSCLC) is a rare molecular subtype, accounting for 1-2% of all lung cancers. Selpercatinib, a selective RET tyrosine kinase inhibitor (TKI), has demonstrated effica...